Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.

Phosphorus Assay in Column Chromatography

1959 • 12,895 citations

Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

1982 • 1,241 citations

Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

1979 • 1,203 citations

Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment.

1981 • 446 citations

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives

1980 • 422 citations

Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

1981 • 390 citations

Nonimmunological Production pf Leukotrienes Induced by Platelet-Activating Factor

1982 • 305 citations

Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

1980 • 259 citations

Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

1983 • 247 citations

Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs

1983 • 243 citations

1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.

1981 • 237 citations

Thromboxane A2 Mediates Augmented Polymorphonuclear Leukocyte Adhesiveness

1980 • 205 citations

Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

1984 • 203 citations

Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.

1982 • 194 citations

Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.

1982 • 177 citations

Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituents

1980 • 150 citations

Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine

1981 • 134 citations

Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.

1984 • 123 citations

Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.

1980 • 123 citations

Pulmonary injury induced by C3a and C5a anaphylatoxins.

1980 • 116 citations

Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).

1982 • 115 citations

Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

1983 • 115 citations

Acute microvascular effects of PAF-acether, as studied by intravital microscopy

1983 • 114 citations

Anaphylactic actions of platelet-activating factor.

1981 • 108 citations

Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.

1984 • 105 citations

Endothelial changes induced by arterial spasm.

1981 • 96 citations

A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.

1980 • 95 citations

Acute inflammatory pulmonary reactions induced by chemotactic factors.

1979 • 89 citations

Effect of pulmonary blood flow on the exchange between the circulating and marginating pool of polymorphonuclear leukocytes in dog lungs.

1982 • 89 citations

Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.

1983 • 86 citations

Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.

1980 • 83 citations

Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine.

1982 • 82 citations

Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.

1983 • 75 citations

Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.

1981 • 74 citations

An In Vivo Model for Studying Platelet Aggregation and Disaggregation

1982 • 70 citations

The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships.

1984 • 59 citations

Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

1981 • 55 citations

Pathophysiological mechanisms of sudden death induced by platelet activating factor

1984 • 53 citations

The pulmonary response of C5 sufficient and deficient mice to immune complexes.

1981 • 46 citations

Platelet-activating factor effects on pulmonary ultrastructure in rabbits

1983 • 33 citations

Platelet-Activating Factor Causes Neutrophil Accumulation and Edema in Rabbit Lungs

1983 • 31 citations

Synergistic interaction between prostaglandins and paf-acether in experimental animals and man

1984 • 31 citations

Pulmonary injury induced by phorbol myristate acetate following intravenous administration in rabbits. Acute respiratory distress followed by pulmonary interstitial pneumonitis and pulmonary fibrosis.

1983 • 29 citations

Release of a slow-reacting substance from rabbit platelets.

1981 • 29 citations

Pulmonary intravascular sequestration of activated neutrophils: failure to induce light-microscopic evidence of lung injury in rabbits.

1982 • 29 citations

Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit

1983 • 27 citations

Lung injury induced by antibody fragments to angiotensin-converting enzyme.

1981 • 26 citations

Inhibitory effect of prostacyclin (PGI2) on neutropenia induce by intravenous injection of platelet-activating-factor (PAF) in the rabbit

1983 • 25 citations

Platelet-activating factor-mediated contraction of rabbit lung strips: Pharmacologic modulation

1983 • 23 citations

Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function.

1985 • 20 citations

Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).

1983 • 20 citations